Edwards Lifesciences company profile
Company profile
Edwards Lifesciences has 16,000 employees and is headquartered in Irvine, United States.
Edwards Lifesciences sells products and technologies for the treatment of advanced cardiovascular diseases to patients and clinicians in the United States, Europe, Japan and other international markets. Its core offering is transcatheter heart valve therapy, including the SAPIEN valve family for replacing aortic valves without open-heart surgery and the PASCAL and EVOQUE systems for treating mitral and tricuspid valve disease. The company also supplies surgical structural heart products such as the INSPIRIS and INSPIRIS RESILIA aortic valves, the KONECT RESILIA valve conduit and the MITRIS RESILIA valve. Its products reach hospitals through a direct sales force and independent distributors.
In the fiscal year ended December 2025, Edwards Lifesciences reported revenue of $6.1 billion, up 11.5% from the previous year, and net income of $1.1 billion. The company, founded in 1958, employs 16,000 people and is headquartered in Irvine, California.
Company facts
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Headquarters
- One Edwards Way, 92614, Irvine
- Employees
- 16,000
- Chief executive
- Bernard Zovighian
- Founded
- 1958
- Fiscal year
- January - December
- Listing
- EW · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US28176E1082
- Website
- edwards.com
Edwards Lifesciences and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Edwards LifesciencesEW | United States | $61.59B | 16,000 | 28.8% | 61.6 |
| Boston ScientificBSX | United States | $63.33B | 59,000 | 19.6% | 18.4 |
| GE HealthCare TechnologiesGEHC | United States | $37B | 54,000 | 13.8% | 17.3 |
| StrykerSYK | United States | $118.29B | 56,000 | 24.0% | 33.1 |
| DexComDXCM | United States | $30.44B | 11,000 | 24.0% | 32.1 |
| MedtronicMDT | United States | $130.88B | 95,000 | 20.1% | 25.1 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
